🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

6,931 results for “The” Clear

  1. Minocycline

    The First People's Hospital of Lianyungang

    Ischemic Stroke, Acute

    approved small molecule active

    2 trials

  2. Mitapivat

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    approved small molecule active

    2 trials

  3. Montelukast

    The First People's Hospital of Lianyungang

    Sinusitis

    approved small molecule completed

    1 trial

  4. Monthly Review Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  5. Morfina cloridrato S.A.L.F. 10 mg/ml soluzione iniettabile, ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M. 10 mg/ml soluzione iniettabile, CATAPRESAN 150 microgrammi/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    cesarean section

    approved small molecule active

    1 trial

  6. Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  7. Moxonidine 0.2 MG

    Hospital Authority, Hong Kong

    Central Sympathetic Nervous System Diseases

    approved small molecule completed

    1 trial

  8. NAC

    United Therapeutics Europe Ltd

    Effects of High Altitude

    approved small molecule terminated

    1 trial

  9. Nelfinavir and Omeprazole

    Jasper Therapeutics

    Healthy Volunteers

    approved small molecule completed

    1 trial

  10. Nerve block with liposomal bupivacaine and intravenous analgesia

    The First People's Hospital of Lianyungang

    Liposomal Bupivacaine

    approved other active

    1 trial

  11. Nifedipine GITS

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  12. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  13. Nocardia rubra Cell Wall Skeleton

    The First People's Hospital of Lianyungang

    Diabetic Foot Ulcer

    approved small molecule active

    1 trial

  14. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  15. OMACOR

    United Therapeutics Europe Ltd

    Non-Alcoholic Fatty Liver Disease

    approved small molecule completed

    1 trial

  16. OPDIVO 10 mg/mL concentrate for solution for infusion., CABOMETYX 20 mg film-coated tablets, CABOMETYX 40 mg film-coated tablets

    The George Institute

    Renal carcinoma

    approved small molecule active

    1 trial

  17. ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, RoActemra 162 mg solution for injection in pre-filled syringe., ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg solution for injection in pre-filled syringe, ORENCIA 125 mg sol

    The George Institute

    Adults patients suffering from rheumatoid arthritis and in adequate response to one or two targeted treatments.

    approved small molecule active

    1 trial

  18. Ocrevus 300 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Multiple Sclerosis (MS) or Clinically Isolated Syndrome (CIS) [in line with the locally approved indications]

    approved small molecule active

    1 trial

  19. Offer of voucher for cost-free Nicotine Replacement Therapy

    United Therapeutics Europe Ltd

    Tobacco Smoking

    approved small molecule completed

    1 trial

  20. Olanzapine

    United Therapeutics Europe Ltd

    Acute Agitation, Behavioural Emergency

    approved small molecule terminated

    1 trial

  21. Omega 3-Atorvastatin

    United Therapeutics Europe Ltd

    Dyslipidemias

    approved small molecule active

    1 trial

  22. Optimal hypoglycemic treatment

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    approved other active

    1 trial

  23. Oral Zonisamide Therapy

    Affiliated Hospital of Nantong University

    Epilepsies, Partial

    approved small molecule active

    1 trial

  24. Oral hygiene intervention

    The University of Hong Kong

    Acute Stroke

    approved other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources